{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T09:00:59Z","timestamp":1791277259752,"version":"4.1.0"},"reference-count":25,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"9","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2021,9]]},"abstract":"<jats:sec>\n            <jats:title>Background:<\/jats:title>\n            <jats:p>Central venous lines (CVLs) are essential for standard care of pediatric hematology\/oncology patients providing safe administration of cytotoxic drugs and pain-free blood sampling. Central line\u2013associated bloodstream infections (CLABSIs) cause significant morbidity. This study describes the epidemiology, microbiology, and risk factors for CLABSI in all children with malignancies in Iceland.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods:<\/jats:title>\n            <jats:p>All children that were diagnosed with malignancy in Iceland and received a CVL during 2008\u20132017 were included in the study. Characteristics of CVLs and patients were registered, information on risk factors, and microbiology was collected. International standards were used for CLABSI definition.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results:<\/jats:title>\n            <jats:p>One hundred forty-three CVLs were placed in 94 children. Acute lymphoblastic leukemia was the most common underlying disease (31\/94). Median age was 7 years. Implantable ports were the most commonly placed CVLs (82\/143, 57%), tunneled lines were 39 (27%). Overall CLABSI rate was 0.24 infections\/1000 line-days (14 episodes in 58,830 line-days), with little fluctuations. No CLABSI episodes occurred for 4 consecutive years (2012\u20132015). Staphylococci (of which 7 <jats:italic toggle=\"yes\">Staphylococcus aureus<\/jats:italic>) were the cause of 10\/14 episodes. Nine CLABSI episodes led to line removal, but no deaths were linked to CLABSIs.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusion:<\/jats:title>\n            <jats:p>We report very low CLABSI rates over a 9-year period at our hospital, with 4 consecutive CLABSI-free years. Even with the addition of episodes of possible CLABSI, rates were still very low and lower than most published reports.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/inf.0000000000003177","type":"journal-article","created":{"date-parts":[[2021,5,15]],"date-time":"2021-05-15T02:02:57Z","timestamp":1621044177000},"page":"827-831","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":6,"title":["Low Risk of Central Line\u2013associated Bloodstream Infections in Pediatric Hematology\/Oncology Patients"],"prefix":"10.1097","volume":"40","author":[{"given":"Iris","family":"Kristinsdottir","sequence":"first","affiliation":[{"name":"Faculty of Medicine, University of Iceland"},{"name":"Children\u2018s Hospital Iceland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Asgeir","family":"Haraldsson","sequence":"additional","affiliation":[{"name":"Faculty of Medicine, University of Iceland"},{"name":"Children\u2018s Hospital Iceland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olafur","family":"Gudlaugsson","sequence":"additional","affiliation":[{"name":"Division of Infection Control, Landspitali\u2014University Hospital of Iceland."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Valtyr","family":"Thors","sequence":"additional","affiliation":[{"name":"Faculty of Medicine, University of Iceland"},{"name":"Children\u2018s Hospital Iceland"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2021,5,7]]},"reference":[{"key":"R1-20250922","doi-asserted-by":"crossref","first-page":"1894","DOI":"10.1016\/j.jpedsurg.2018.10.054","article-title":"Incidence, severity and outcome of central line related complications in pediatric oncology patients; a single center study.","volume":"54","author":"van den Bosch","year":"2019","journal-title":"J Pediatr Surg"},{"key":"R2-20250922","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1007\/s00277-016-2634-x","article-title":"A comprehensive approach to the prevention of central venous catheter complications: results of 10-year prospective surveillance in pediatric hematology-oncology patients.","volume":"95","author":"Cesaro","year":"2016","journal-title":"Ann Hematol"},{"key":"R3-20250922","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1002\/pbc.22286","article-title":"Complications and risk factors of infection in pediatric hemato-oncology patients with totally implantable access ports (TIAPs).","volume":"54","author":"Nam","year":"2010","journal-title":"Pediatr Blood Cancer"},{"key":"R4-20250922","doi-asserted-by":"crossref","first-page":"e1525","DOI":"10.1542\/peds.2013-3795","article-title":"Attributable cost and length of stay for central line-associated bloodstream infections.","volume":"133","author":"Goudie","year":"2014","journal-title":"Pediatrics"},{"key":"R5-20250922","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1097\/INF.0000000000001849","article-title":"Clinical characteristics and risk factors of long-term central venous catheter-associated bloodstream infections in children.","volume":"37","author":"Moon","year":"2018","journal-title":"Pediatr Infect Dis J"},{"key":"R6-20250922","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1086\/599376","article-title":"Clinical practice guidelines for the diagnosis and management of intravascular catheter-related infection: 2009 update by the infectious diseases society of America.","volume":"49","author":"Mermel","year":"2009","journal-title":"Clin Infect Dis"},{"key":"R7-20250922","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1097\/INF.0000000000002495","article-title":"Central venous catheter management in high-risk children with bloodstream infections.","volume":"39","author":"Hecht","year":"2020","journal-title":"Pediatr Infect Dis J"},{"key":"R8-20250922","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1086\/656246","article-title":"Risk factors for central line-associated bloodstream infection in pediatric intensive care units.","volume":"31","author":"Wylie","year":"2010","journal-title":"Infect Control Hosp Epidemiol"},{"key":"R9-20250922","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.1016\/j.ajic.2014.07.025","article-title":"Attributable costs of central line-associated bloodstream infections in a pediatric hematology\/oncology population.","volume":"42","author":"Wilson","year":"2014","journal-title":"Am J Infect Control"},{"key":"R10-20250922","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1017\/ice.2016.83","article-title":"Risk factors for central venous catheter-associated bloodstream infection in pediatric patients: a Cohort Study.","volume":"37","author":"Carter","year":"2016","journal-title":"Infect Control Hosp Epidemiol"},{"key":"R11-20250922","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1016\/j.jhin.2005.08.019","article-title":"Infectious complications of implantable ports and Hickman catheters in paediatric haematology-oncology patients.","volume":"62","author":"Adler","year":"2006","journal-title":"J Hosp Infect"},{"key":"R12-20250922","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1086\/662376","article-title":"Moving CLABSI prevention beyond the intensive care unit: risk factors in pediatric oncology patients.","volume":"32","author":"Kelly","year":"2011","journal-title":"Infect Control Hosp Epidemiol"},{"key":"R13-20250922","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1002\/pbc.21497","article-title":"Risk determinants for catheter-associated blood stream infections in children and young adults with cancer.","volume":"51","author":"Allen","year":"2008","journal-title":"Pediatr Blood Cancer"},{"key":"R14-20250922","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1002\/pbc.26225","article-title":"Risk factors for central line-associated bloodstream infection in pediatric oncology patients with a totally implantable venous access port: a cohort study.","volume":"64","author":"Viana Taveira","year":"2017","journal-title":"Pediatr Blood Cancer"},{"key":"R15-20250922","doi-asserted-by":"crossref","first-page":"e194","DOI":"10.1097\/MPH.0b013e318290c24f","article-title":"Prospective surveillance study of blood stream infections associated with central venous access devices (port-type) in children with acute leukemia: an intervention program.","volume":"35","author":"Berrueco","year":"2013","journal-title":"J Pediatr Hematol Oncol"},{"key":"R16-20250922","article-title":"Centers for Disease Control and Prevention, and the National Healthcare Safety Network.","year":"2018"},{"key":"R17-20250922","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1111\/ped.13289","article-title":"Central line-associated bloodstream infection in childhood malignancy: single-center experience.","volume":"59","author":"Miliaraki","year":"2017","journal-title":"Pediatr Int"},{"key":"R18-20250922","doi-asserted-by":"crossref","first-page":"4368","DOI":"10.1002\/cncr.25286","article-title":"Severe neutropenia at time of port insertion is not a risk factor for catheter-associated infections in children with acute lymphoblastic leukemia.","volume":"116","author":"Junqueira","year":"2010","journal-title":"Cancer"},{"key":"R19-20250922","doi-asserted-by":"crossref","first-page":"e996","DOI":"10.1542\/peds.2012-0295","article-title":"Implementation of a central line maintenance care bundle in hospitalized pediatric oncology patients.","volume":"130","author":"Rinke","year":"2012","journal-title":"Pediatrics"},{"key":"R20-20250922","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1093\/cid\/cir523","article-title":"Defining bloodstream infections related to central venous catheters in patients with cancer: a systematic review.","volume":"53","author":"Tomlinson","year":"2011","journal-title":"Clin Infect Dis"},{"key":"R21-20250922","doi-asserted-by":"crossref","first-page":"1882","DOI":"10.1002\/pbc.24677","article-title":"Ambulatory pediatric oncology CLABSIs: epidemiology and risk factors.","volume":"60","author":"Rinke","year":"2013","journal-title":"Pediatr Blood Cancer"},{"key":"R22-20250922","doi-asserted-by":"crossref","first-page":"e1678","DOI":"10.1542\/peds.2014-0582","article-title":"Preventing CLABSIs among pediatric hematology\/oncology inpatients: national collaborative results.","volume":"134","author":"Bundy","year":"2014","journal-title":"Pediatrics"},{"key":"R23-20250922","doi-asserted-by":"crossref","first-page":"690","DOI":"10.1017\/ice.2017.57","article-title":"A prospective, holistic, multicenter approach to tracking and understanding bloodstream infections in pediatric hematology-oncology patients.","volume":"38","author":"Gaur","year":"2017","journal-title":"Infect Control Hosp Epidemiol"},{"key":"R24-20250922","first-page":"Doc11","article-title":"Surveillance of bloodstream infections in pediatric cancer centers\u2014what have we learned and how do we move on?","volume":"11","author":"Simon","year":"2016","journal-title":"GMS Hyg Infect Control"},{"key":"R25-20250922","doi-asserted-by":"crossref","first-page":"1108","DOI":"10.1093\/cid\/cir145","article-title":"Central line-associated bloodstream infection in hospitalized children with peripherally inserted central venous catheters: extending risk analyses outside the intensive care unit.","volume":"52","author":"Advani","year":"2011","journal-title":"Clin Infect Dis"}],"container-title":["Pediatric Infectious Disease Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/INF.0000000000003177","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,22]],"date-time":"2025-09-22T13:03:13Z","timestamp":1758546193000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/INF.0000000000003177"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,5,7]]},"references-count":25,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2021]]}},"URL":"https:\/\/doi.org\/10.1097\/inf.0000000000003177","relation":{},"ISSN":["0891-3668"],"issn-type":[{"value":"0891-3668","type":"print"}],"subject":[],"published":{"date-parts":[[2021,5,7]]}}}